122 related articles for article (PubMed ID: 32598682)
1. [Endothelial damage and circadian blood pressure profile in rheumatoid arthritis].
Shilkina NP; Yunonin IE; Butusova SV; Mikhailova EV; Vinogradov AA
Ter Arkh; 2019 May; 91(5):89-95. PubMed ID: 32598682
[TBL] [Abstract][Full Text] [Related]
2. [Cerebral perfusion, arterial hypertension and endothelial dysfunction in rheumatoid arthritis].
Shilkina NP; Spirin NN; Yunonin IE; Vinogradov AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3. Vyp. 2):68-75. PubMed ID: 31184627
[TBL] [Abstract][Full Text] [Related]
3. [Markers of endothelial activation in rheumatoid arthritis].
Shilikina NP; Yunonin IE; Vinogradov AA; Butusova SV
Ter Arkh; 2012; 84(8):29-32. PubMed ID: 22994085
[TBL] [Abstract][Full Text] [Related]
4. [System of microcirculation, markers of vascular wall damage and systematicity of the process in rheumatic diseases].
Shilkina NP; Butusova SV; Driazhenkova IV
Angiol Sosud Khir; 2014; 20(1):27-34. PubMed ID: 24722018
[TBL] [Abstract][Full Text] [Related]
5. [Endothelial dysfunction in rheumatic patients].
Shilkina NP; Butusova SV
Klin Med (Mosk); 2013; 91(4):58-61. PubMed ID: 23879057
[TBL] [Abstract][Full Text] [Related]
6. [Markers of vascular endothelium activation in gout].
Lapkina NA; Baranov AA; Barskova VG; Abaĭtova NE; Iakunina IA
Ter Arkh; 2005; 77(5):62-5. PubMed ID: 15989007
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease.
de Groot L; Hinkema H; Westra J; Smit AJ; Kallenberg CG; Bijl M; Posthumus MD
Arthritis Res Ther; 2011; 13(6):R205. PubMed ID: 22168993
[TBL] [Abstract][Full Text] [Related]
8. Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients?
de Groot L; Jager NA; Westra J; Smit AJ; Kallenberg CG; Posthumus MD; Bijl M
Rheumatology (Oxford); 2015 Jul; 54(7):1257-61. PubMed ID: 25587178
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.
Dessein PH; Joffe BI; Singh S
Arthritis Res Ther; 2005; 7(3):R634-43. PubMed ID: 15899050
[TBL] [Abstract][Full Text] [Related]
10. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis.
Blann AD; Herrick A; Jayson MI
Br J Rheumatol; 1995 Sep; 34(9):814-9. PubMed ID: 7582719
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment.
Foster W; Carruthers D; Lip GY; Blann AD
J Rheumatol; 2010 Apr; 37(4):711-6. PubMed ID: 20156948
[TBL] [Abstract][Full Text] [Related]
12. Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.
Lau CS; McLaren M; Hanslip J; Kerr M; Belch JJ
Ann Rheum Dis; 1993 Sep; 52(9):643-9. PubMed ID: 8239758
[TBL] [Abstract][Full Text] [Related]
13. Roles of claudin-5 and von Willebrand factor in patients with rheumatoid arthritis.
Gurol G; Ciftci IH; Harman H; Karakece E; Kamanli A; Tekeoglu I
Int J Clin Exp Pathol; 2015; 8(2):1979-84. PubMed ID: 25973092
[TBL] [Abstract][Full Text] [Related]
14. Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis.
Wållberg-Jonsson S; Caidahl K; Klintland N; Nyberg G; Rantapää-Dahlqvist S
Scand J Rheumatol; 2008; 37(1):1-5. PubMed ID: 18189187
[TBL] [Abstract][Full Text] [Related]
15. Effects of severe, uncontrolled hypertension on endothelial activation: soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1 and von Willebrand factor.
Preston RA; Ledford M; Materson BJ; Baltodano NM; Memon A; Alonso A
J Hypertens; 2002 May; 20(5):871-7. PubMed ID: 12011647
[TBL] [Abstract][Full Text] [Related]
16. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
Kerekes G; Soltész P; Szucs G; Szamosi S; Dér H; Szabó Z; Csáthy L; Váncsa A; Szodoray P; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2011 Mar; 13(3):147-52. PubMed ID: 21608334
[TBL] [Abstract][Full Text] [Related]
17. Is small artery elasticity decreased prior to intima-media thickening in patients with longstanding rheumatoid arthritis?
Hinkema HJ; Nienhuis HL; de Groot L; Smit AJ; van Roon AM; Bijl M; Posthumus MD
J Rheumatol; 2011 Oct; 38(10):2133-40. PubMed ID: 21844153
[TBL] [Abstract][Full Text] [Related]
18. Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction.
Foster W; Shantsila E; Carruthers D; Lip GY; Blann AD
Rheumatology (Oxford); 2009 Mar; 48(3):285-8. PubMed ID: 19153145
[TBL] [Abstract][Full Text] [Related]
19. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
Jezovnik MK; Poredos P
Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
